RECOMBINATE 500 IU

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Доступна з:

TEVA MEDICAL MARKETING LTD.

Код атс:

B02BD05

Фармацевтична форма:

POWDER FOR SOLUTION FOR INJECTION

Адміністрація маршрут:

I.V

Виробник:

BAXTER S.A., BELGIUM

Терапевтична група:

COAGULATION FACTOR VII

Терапевтичні свідчення:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Дата Авторизація:

2010-07-01